Antenatal Obesity Treatment for Pregnancy-Related Obesity
(GWG Trial)

Recruiting in Palo Alto (17 mi)

Overseen BySharon J. Herring, MD, MPH

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Temple University

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to determine the effect of an antenatal obesity treatment on gestational weight gain when integrated into Philadelphia WIC.

Eligibility Criteria

This trial is for African American or Hispanic women who are part of the Philadelphia WIC program, have a BMI ≥ 25 kg/m2, and are less than 16 weeks pregnant. They must own a cell phone with unlimited texting and be able to do light exercises like walking. Women with certain medical conditions or those who've had bariatric surgery can't join.

Inclusion Criteria

BMI ≥ 25 kg/m2

Gestational age ≤16 weeks' (measured using last menstrual period)

I can walk and do some light to moderate physical activities.

+4 more

Exclusion Criteria

I have had weight loss surgery in the past.

I have a health condition like diabetes or thyroid issues that can affect my weight.

Shared phone

+4 more

Participant Groups

The study is testing an antenatal obesity treatment (AO) designed to manage weight gain during pregnancy. It's integrated into the Philadelphia WIC program and involves receiving texts as part of the intervention.

2Treatment groups

Experimental Treatment

Active Control

Group I: Antenatal Obesity Treatment (AO)Experimental Treatment1 Intervention

The AO arm consists of a multi-component, theory- and evidence-based intervention and includes weight-related behavior change through goal setting and self-monitoring, behavioral skills training, interpersonal support, and social modeling strategies.

Group II: WIC Standard Care (SC)Active Control1 Intervention

Participants assigned to the WIC standard care arm will receive usual care offered to pregnant women at WIC.